163 related articles for article (PubMed ID: 24964769)
1. P14ARF deficiency and its correlation with overexpression of p53/MDM2 in sporadic vestibular schwannomas.
Chen Y; Wang ZY; Wu H
Eur Arch Otorhinolaryngol; 2015 Sep; 272(9):2227-34. PubMed ID: 24964769
[TBL] [Abstract][Full Text] [Related]
2. Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer.
Wang YC; Lin RK; Tan YH; Chen JT; Chen CY; Wang YC
J Clin Oncol; 2005 Jan; 23(1):154-64. PubMed ID: 15625370
[TBL] [Abstract][Full Text] [Related]
3. MDM2 mRNA expression in the p53 pathway may predict the potential of invasion and liver metastasis in colorectal cancer.
Kondo I; Iida S; Takagi Y; Sugihara K
Dis Colon Rectum; 2008 Sep; 51(9):1395-402. PubMed ID: 18607552
[TBL] [Abstract][Full Text] [Related]
4. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical inactivation of p14ARF concomitant with MDM2 overexpression inversely correlates with p53 overexpression in oral squamous cell carcinoma.
Sano T; Hikino T; Xue Q; Saito T; Kashiwabara K; Oyama T; Nakajima T
Pathol Int; 2000 Sep; 50(9):709-16. PubMed ID: 11012984
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer.
Agrawal A; Yang J; Murphy RF; Agrawal DK
Exp Mol Pathol; 2006 Oct; 81(2):115-22. PubMed ID: 16919268
[TBL] [Abstract][Full Text] [Related]
7. Relationship between p53-associated proteins and estrogen receptor status in ovarian serous neoplasms.
Cho EY; Choi YL; Chae SW; Sohn JH; Ahn GH
Int J Gynecol Cancer; 2006; 16(3):1000-6. PubMed ID: 16803476
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the p14ARF-p53-MDM2 pathway in oral squamous cell carcinoma: MDM2 overexpression is a common event.
Lim KP; Sharifah H; Lau SH; Teo SH; Cheong SC
Oncol Rep; 2005 Oct; 14(4):963-8. PubMed ID: 16142358
[TBL] [Abstract][Full Text] [Related]
9. Dysfunction of p53 pathway in human colorectal cancer: analysis of p53 gene mutation and the expression of the p53-associated factors p14ARF, p33ING1, p21WAF1 and MDM2.
Tachibana M; Kawamata H; Fujimori T; Omotehara F; Horiuchi H; Ohkura Y; Igarashi S; Kotake K; Kubota K
Int J Oncol; 2004 Oct; 25(4):913-20. PubMed ID: 15375540
[TBL] [Abstract][Full Text] [Related]
10. p53 Pathway dysfunction in primary childhood ependymomas.
Gaspar N; Grill J; Geoerger B; Lellouch-Tubiana A; Michalowski MB; Vassal G
Pediatr Blood Cancer; 2006 May; 46(5):604-13. PubMed ID: 16086408
[TBL] [Abstract][Full Text] [Related]
11. p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2.
Esteller M; Cordon-Cardo C; Corn PG; Meltzer SJ; Pohar KS; Watkins DN; Capella G; Peinado MA; Matias-Guiu X; Prat J; Baylin SB; Herman JG
Cancer Res; 2001 Apr; 61(7):2816-21. PubMed ID: 11306450
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor β1 (TGF-β1) suppresses growth of B-cell lymphoma cells by p14(ARF)-dependent regulation of mutant p53.
Chen G; Ghosh P; O'Farrell T; Munk R; Rezanka LJ; Sasaki CY; Longo DL
J Biol Chem; 2012 Jun; 287(27):23184-95. PubMed ID: 22621932
[TBL] [Abstract][Full Text] [Related]
13. Age dependent phosphorylation and deregulation of p53 in human vestibular schwannomas.
Dayalan AH; Jothi M; Keshava R; Thomas R; Gope ML; Doddaballapur SK; Somanna S; Praharaj SS; Ashwathnarayanarao CB; Gope R
Mol Carcinog; 2006 Jan; 45(1):38-46. PubMed ID: 16299809
[TBL] [Abstract][Full Text] [Related]
14. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
[TBL] [Abstract][Full Text] [Related]
15. Involvement of p21 (waf1) in merlin deficient sporadic vestibular schwannomas.
Wu H; Chen Y; Wang ZY; Li W; Li JQ; Zhang L; Lu YJ
Neuroscience; 2010 Sep; 170(1):149-55. PubMed ID: 20600642
[TBL] [Abstract][Full Text] [Related]
16. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.
Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC
Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146
[TBL] [Abstract][Full Text] [Related]
17. Different expression pattern and significance of p14ARF-Mdm2-p53 pathway and Bmi-1 exist between gastric cardia and distal gastric adenocarcinoma.
Yao D; Wang Y; Xue L; Wang H; Zhang J; Zhang X
Hum Pathol; 2013 May; 44(5):844-51. PubMed ID: 23159155
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.
Chen H; Xue L; Huang H; Wang H; Zhang X; Zhu W; Wang Z; Wang Z; Wu H
EBioMedicine; 2018 Oct; 36():252-265. PubMed ID: 30274821
[TBL] [Abstract][Full Text] [Related]
19. Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapse.
Carr J; Bell E; Pearson AD; Kees UR; Beris H; Lunec J; Tweddle DA
Cancer Res; 2006 Feb; 66(4):2138-45. PubMed ID: 16489014
[TBL] [Abstract][Full Text] [Related]
20. Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14(ARF)-MDM2-p53 axis.
Van Maerken T; Vandesompele J; Rihani A; De Paepe A; Speleman F
Cell Death Differ; 2009 Dec; 16(12):1563-72. PubMed ID: 19779493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
